Abstract
There are many chemotherapeutic interventions available for tuberculosis (TB) and are in use for more than five decades, but still there is an urgent need for novel drugs against new targets due to emergence of resistant strains. Moreover, the ability of Mycobacterium tuberculosis (Mtb) to survive within granulomas in a non-replicating latent stage prolongs the course of drug dose and hence increases the severity of the disease. The significant rerouting of metabolism is one of the key processes that help mycobacteria adapt to the hostile environment of host granuloma. In this review, we are focusing on some of the cofactor biosynthetic pathways of Mycobacterium tuberculosis and their utilization as drug targets.
Current Respiratory Medicine Reviews
Title:Cofactor Biosynthetic Pathways in Mycobacterium tuberculosis as Potential Drug Targets
Volume: 10 Issue: 2
Author(s): Shilpika Pandey, Sarthak Gaur, Neha Topno, Sidharth Chopra and Arunava Dasgupta
Affiliation:
Keywords: FAD, Mtb, NAD, Pantothenate, iron, vitamin.
Abstract: There are many chemotherapeutic interventions available for tuberculosis (TB) and are in use for more than five decades, but still there is an urgent need for novel drugs against new targets due to emergence of resistant strains. Moreover, the ability of Mycobacterium tuberculosis (Mtb) to survive within granulomas in a non-replicating latent stage prolongs the course of drug dose and hence increases the severity of the disease. The significant rerouting of metabolism is one of the key processes that help mycobacteria adapt to the hostile environment of host granuloma. In this review, we are focusing on some of the cofactor biosynthetic pathways of Mycobacterium tuberculosis and their utilization as drug targets.
Export Options
About this article
Cite this article as:
Pandey Shilpika, Gaur Sarthak, Topno Neha, Chopra Sidharth and Dasgupta Arunava, Cofactor Biosynthetic Pathways in Mycobacterium tuberculosis as Potential Drug Targets, Current Respiratory Medicine Reviews 2014; 10 (2) . https://dx.doi.org/10.2174/1573398X10666140822004506
DOI https://dx.doi.org/10.2174/1573398X10666140822004506 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cytokine/Antibody Complexes: An Emerging Class of Immunostimulants
Current Pharmaceutical Design Depsipeptides from Microorganisms: A New Class of Antimalarials
Mini-Reviews in Medicinal Chemistry UPLC-ESI-Q-TOF/MS Based Metabolic Profiling of Protosappanin B in Rat Plasma, Bile, Feces, Urine and Intestinal Bacteria Samples
Current Drug Metabolism 2', 4'-dihydroxy-3, 4-methylenedioxychalcone Activate Mitochondrial Apoptosis of Ehrlich Ascites Carcinoma Cells
Current Drug Therapy Inhibitors of Mycothiol-S-Conjugate Amidase and Related Genes
Current Medicinal Chemistry - Anti-Infective Agents Body Mass Index (BMI) and Cognitive Functions in Later Life
Current Alzheimer Research Prevention and Therapeutic Strategies of Thromboembolic Events in Patients with Inflammatory Bowel Diseases: A Report of Three Cases
Current Drug Targets New Perspectives on Machine Learning in Drug Discovery
Current Medicinal Chemistry Intelligently Applying Artificial Intelligence in Chemoinformatics
Current Topics in Medicinal Chemistry The Metabolomic Strategy in Tuberculosis Therapy
Combinatorial Chemistry & High Throughput Screening Toxic Effects of Aflatoxin B1 on Embryonic Development of Zebrafish (Danio rerio): Potential Activity of Piceatannol Encapsulated Chitosan/poly (Lactic Acid) Nanoparticles
Anti-Cancer Agents in Medicinal Chemistry Patent Selections
Recent Patents on Anti-Infective Drug Discovery Tuberculosis of the Thymus: A Case Report and Review of the Literature
Current Respiratory Medicine Reviews Adenovirus Vectors for Gene Therapy, Vaccination and Cancer Gene Therapy
Current Gene Therapy Editorial
Current Molecular Medicine Particulate Systems as Adjuvants and Carriers for Peptide and Protein Antigens
Current Drug Delivery Spontaneous Pneumothorax
Current Respiratory Medicine Reviews Effect of Sulfonamides on the Electrophysical Properties of Bacterial Cells
Anti-Infective Agents Challenges Associated with Current and Future TB Treatment
Infectious Disorders - Drug Targets Radziszewski Reaction: An Elegant, Easy, Simple and Efficient Method to Synthesise Imidazoles
Current Organic Synthesis